DUBAI/WAM The Ministry of Education has announced the approval of mandatory guidelines for the teaching ...
Read More »Novartis’s new CEO has cash, momentum for an overhaul
Asset swaps have been a big thing in pharma over the past few years. Now it’s time for the un-swap. Novartis AG said it was unwinding part of a complicated 2014 asset swap with GlaxoSmithKline PLC, trading its stake in their consumer-health joint venture for $13 billion. The decision isn’t a huge surprise, though the timing is unexpected. It suggests ...
Read More »